Dr. Sharmila Anandasabapathy: Ask Me About My Research
Director of Baylor Global Health and professor of medicine - gastroenterology Sharmila Anandasabapathy, M.D. is joined by a special guest to demonstrate the importance of scientists and researchers talking with others about their work.
About Our Research
The Section of Gastroenterology and Hepatology participates in research through the:
- Texas Medical Center Digestive Disease Center
- Texas Hepatocellular Carcinoma Consortium
- Texas Collaborative Center for Hepatocellular Cancer
- Center for Innovations in Quality, Effectiveness and Safety
- Dan L Duncan Comprehensive Cancer Center
The Texas Medical Center Digestive Disease Center is a federally funded center designed to serve basic and clinical scientists at institutions within the Texas Medical Center (Baylor College of Medicine and The University of Texas Health Science Center at Houston) and at The University of Texas Medical Branch in Galveston.
The center facilitates ongoing digestive diseases research, promote translational research between basic and clinical areas, develop new projects, nurture new investigators, and provide GI educational activities. The DDC supports four basic science cores (morphology, cell and molecular biology, gastrointestinal immunology, and integrative biology) and one clinical core (study design and specimen collection).
Pilot/feasibility and enrichment programs to support innovative ideas and new investigators in digestive disease research and foster collaboration are a key part of our center. The center draws together a multidisciplinary group of investigators, including basic scientists with proven track records of success, and well coordinated clinical programs dealing with pediatric and adult GI patients.
Research Areas
See the sections below to learn about our research areas and projects.
New tool to predict outcomes in cirrhosis of the liver
Our researchers have developed a model using a blend of artificial intelligence and traditional statistical methods to produce a score better predicting mortality in cirrhosis.
Baylor awarded CPRIT grants for cancer research and prevention programs
Baylor received two grants as part of the Collaborative Action Program to Reduce Liver Cancer Mortality in Texas, a statewide initiative to reduce the rates of liver cancer, including the most common type, hepatocellular cancer.